Immune Deficiency Articles & Analysis
9 news found
About VAX-24 VAX-24 is an investigational 24-valent PCV candidate designed to prevent IPD and pneumonia, which can be most serious for infants, young children, older adults and those with immune deficiencies or certain chronic health conditions. The public health community continues to affirm the need for vaccines that offer broader protection to prevent IPD and ...
About VAX-24 VAX-24 is an investigational 24-valent PCV candidate designed to prevent IPD and pneumonia, which can be most serious for infants, young children, older adults and those with immune deficiencies or certain chronic health conditions. The public health community continues to affirm the need for vaccines that offer broader protection to prevent IPD and ...
About VAX-24 VAX-24 is an investigational 24-valent PCV candidate designed to prevent IPD, which can be most serious for infants, young children, older adults and those with immune deficiencies or certain chronic health conditions. The public health community continues to affirm the need for vaccines that offer broader protection to prevent pneumococcal disease. ...
“These investigational multi-VST therapies aim to restore immunity against viruses that, if left untreated, can have devastating consequences. ...
ByKalaris
Alpha-1 Biologics, a biotherapeutics company developing innovative treatments for cancers and immune deficiencies, today announced that positive data was published in frontiers in Oncology demonstrating Alphataxin, a small molecule that elevates circulating and tumor-infiltrating CD4+ T cells, suppressed kidney cancer and suppressed metastasis in mice. Orally ...
About CSL CSL (ASX:CSL) is a leading global biotechnology company with a dynamic portfolio of life-saving medicines, including those that treat hemophilia and immune deficiencies, as well as vaccines to prevent seasonal and pandemic influenza. ...
Ariana® Pharma a leading Artificial Intelligence drug development company announced today that it has entered into an Artificial Intelligence-driven Precision Medicine collaboration with Sanofi and leading academic partners targeting autoimmune and inflammatory diseases associated with primary immune deficiencies. The ATRACTion project will generate ...
Although many people may be exposed to it without getting sick, people with weakened immune systems or lung diseases are at higher risk of developing health problems due to exposure. ...
"The funding being provided will allow us to increase education and advocacy for bleeding disorders and healthcare reform at a critical time in the process." The Immune Deficiency Foundation (IDF), Towson, MD IDF will use its LEAD grant to support Capitol Hill Day where individuals with primary immune deficiencies and their ...